FIG 8.
Impact of mitomycin C on ICE_SsaF1-4_fda excision. Fragments corresponding to the recombination sites attB and attI of nontreated (MMC−) or treated (MMC+) cells were amplified by PCR using template DNA quantities ranging from 0.1 μg to 1 pg. The amplification of the fda gene was used as a control.